The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis.
about
Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision makingFasting practices in Tamil Nadu and their importance for patients with diabetesPrevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based StudiesAddition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis55P0110, a Novel Synthetic Compound Developed from a Plant Derived Backbone Structure, Shows Promising Anti-Hyperglycaemic Activity in MiceRisk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study.Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer.Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas.Using Personalized Medicine in the Management of Diabetes Mellitus.The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Balkan Region (Slovenia, Croatia, Serbia, Bulgaria): A Multicenter, Observational, Cross-Sectional Study.Is gliclazide a sulfonylurea with difference? A review in 2016.Risk of severe hypoglycemia in sulfonylurea-treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes.Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures.Pharmacogenomics of CYP2C9: Functional and Clinical Considerations.The Infamous, Famous Sulfonylureas and Cardiovascular Safety: Much Ado About Nothing?Loureirin B promotes insulin secretion through inhibition of KATP channel and influx of intracellular calcium.Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.Trends in the incidence of use of noninsulin glucose-lowering drugs between 2006 and 2013 in France.Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min).Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada.Type 2 diabetes mellitusSkeletal Fragility in Type 2 Diabetes Mellitus
P2860
Q26992979-78C1B374-0386-4F59-9739-502743AB982CQ28078830-33FFB08C-7AAB-4762-95D4-C190858CB019Q28084768-06A21D09-071C-43ED-9BE6-51B40D2D2534Q28275281-A6E1698A-1A1F-451C-B749-558207A13B8CQ28547237-42EF472F-FA9C-472F-B090-B505AC3FF9B9Q37101608-65C546E7-7431-4DAB-BC83-A478719EE61BQ38364806-2B660CD9-9F2D-4FEE-A3F2-9FD703941A36Q38644587-BC1C2A3C-CCFA-4305-9F35-00B3A51C3C01Q38666166-4F44C2B2-E354-4345-9977-3F0A6D9E72ECQ38684834-95685146-2FD7-42E8-99D0-09A735D00BCDQ38754132-A6D8B204-0581-4817-8D3A-F7C6FF13E899Q40498481-E761114D-45E8-4BE2-8D8B-161340152FC0Q40787120-528EFD02-C4AB-400D-8D9B-47CE42661577Q47200528-8FF6B406-312C-41B7-9FD1-E7FFD1C7DF1FQ47570862-D23FAE8D-4CBC-4FD2-ABAF-62F3CD89E6B2Q47733021-67E16F92-EFC3-4FEE-A44D-67701AC80BB1Q47940901-81A718DF-E3BC-4730-B08B-7E2780E6EC80Q48022106-A31E8EFF-964A-473C-9554-3C6D32FF1084Q48334652-AD2D1488-D2CA-4066-8827-F9E25E5469EAQ53519441-42DC03A4-7D00-4A6A-A169-99166E0512C4Q53827419-0659150D-5B98-43BD-B17C-A737AFA8C8D3Q58447602-2A519BC3-ED4E-4DC1-80AF-E4B521BBBA69Q58725004-A1194DB3-4F10-47EC-BAB8-1C7F002FEBF8
P2860
The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The incidence of mild and seve ...... atic review and meta-analysis.
@en
type
label
The incidence of mild and seve ...... atic review and meta-analysis.
@en
prefLabel
The incidence of mild and seve ...... atic review and meta-analysis.
@en
P2093
P2860
P356
P1476
The incidence of mild and seve ...... atic review and meta-analysis.
@en
P2093
A C R Simon
F Holleman
J B L Hoekstra
J E Schopman
R J P M Scholten
S J M Hoefnagel
P2860
P356
10.1002/DMRR.2470
P577
2014-01-01T00:00:00Z